微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 53.49% | 9.37% | 0.56% | 70/142 | 52.32% | 佰仁医疗 | 88.31% | 行业排名> |
| 2026-06-30 | 53.19% | 2.57% | 1.3% | 71/142 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 52.51% | 7.84% | 7.74% | 71/142 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 48.74% | -11.19% | -0.34% | 76/142 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 48.91% | -9.7% | -5.69% | 77/142 | 52.29% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 51.86% | -4.37% | 6.5% | 74/142 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 48.69% | -2.5% | -11.27% | 76/142 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 54.88% | 2.5% | 1.33% | 69/142 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 54.16% | 2.11% | -0.13% | 66/142 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 54.23% | 5.95% | 8.59% | 69/142 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 49.94% | 5.76% | -6.73% | 73/142 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 53.54% | 1.24% | 0.95% | 71/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 53.04% | -1.56% | 3.62% | 71/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 51.19% | -2.56% | 8.4% | 73/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 47.22% | -17.97% | -10.72% | 79/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 52.89% | -11.8% | -1.85% | 73/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 53.88% | -17.22% | 2.58% | 73/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 52.53% | -19.27% | -8.75% | 75/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 57.56% | -12.75% | -4% | 63/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 59.97% | -8.1% | -7.88% | 66/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 65.09% | -0.53% | 0.03% | 48/142 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 65.07% | -0.97% | -1.37% | 51/142 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 65.98% | -1.15% | 1.11% | 45/142 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 65.25% | 0.18% | -0.29% | 57/142 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 65.44% | -0.67% | -0.41% | 40/142 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 65.71% | -0.09% | -1.55% | 44/142 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 66.74% | 0.42% | 2.47% | 28/142 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 65.14% | 2.07% | -1.13% | 54/142 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 65.89% | 3.95% | 0.17% | 23/142 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 65.77% | 2.1% | -1.04% | 31/142 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 66.47% | 5.54% | 4.15% | 17/142 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 63.82% | -5.44% | 0.69% | 46/142 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 63.38% | -4.42% | -1.61% | 21/142 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 64.42% | -2.06% | 2.29% | 25/142 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 62.98% | -6.46% | -6.69% | 20/142 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 67.49% | 5.33% | 1.78% | 36/142 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 66.31% | 4.99% | 0.82% | 16/142 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 65.77% | 8.46% | -2.31% | 20/142 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 67.33% | 15.21% | 5.08% | 13/142 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 64.08% | -2.57% | 1.45% | 34/142 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 63.16% | -3.58% | 4.15% | 12/142 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 60.64% | -6.82% | 3.77% | 19/142 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 58.44% | -13.25% | -11.13% | 11/142 | 50.24% | 健帆生物 | 83.86% | 行业排名> |